PhRMA Discusses Joint 340B Reform Deal with Health Centers in Interview; Hospital Groups Denounce Plan

Nicole Longo
“There is no way for 340B to be fixed without everybody coming to the table,” PhRMA spokesperson Nicole Longo said in an interview with 340B Report.

The fallout continues from drug makers and health centers’ decision to work together to change the 340B program, with the drug industry giving its first interview about the deal to 340B Report on Friday and several hospital groups

Read More »

Connecticut Governor’s First of Its Kind Three-Pronged 340B Bill Passes Hurdle in Legislature

Connecticut House
The Connecticut House might vote soon on a bill to require hospital reporting on 340B revenue, prohibit drug maker restrictions on 340B contract pharmacy use, and prohibit pharmacy benefit manager discrimination against 340B entities and pharmacies.

Connecticut Gov. Ned Lamont’s novel bill to require hospital reporting on 340B revenue, prohibit drug maker restrictions on 340B contract pharmacy use, and prohibit pharmacy benefit manager discrimination against 340B entities and pharmacies has passed its first test

Read More »

U.S. House Subcommittee Could Discuss 340B on Two Consecutive Days This Month

House E&C
The House Energy & Commerce health subcommittee could discuss 340B during hearings on two consecutive days later this month.

U.S. House Republicans yesterday asked Department of Health and Human Services Secretary Xavier Becerra to testify March 29 about the Biden administration’s health care budget request.

Becerra will appear before the Energy & Commerce health subcommittee the day

Read More »

HRSA Wants Reporting Requirements on Use of 340B Savings and Compliance and Reporting Requirements on Use of Contract Pharmacies

HRSA
HRSA is asking Congress for regulatory power to establish “reporting requirements and definitions for the use of [340B] savings and contract pharmacy utilization.”

The U.S. Health Resources and Services Administration has asked Congress for general rulemaking authority over the 340B program so it can establish “reporting requirements and definitions for the use of [340B] savings and contract pharmacy utilization.”

The Biden

Read More »

340B Stakeholders Testify on Conn. Governor’s First-of-Its-Kind Multi-Pronged 340B Legislation

Connecticut state capitol
Connecticut lawmakers heard testimony yesterday on Gov. Ned Lamont’s (D) bill addressing hospitals' 340B revenue, pharma restrictions on 340B contract pharmacy use, and PBM discrimination against 340B entities.

Connecticut 340B stakeholders testified at a state legislative hearing Monday on Gov. Ned Lamont’s (D) comprehensive bill to require hospital reporting on 340B revenue, prohibit drug maker restrictions on 340B contract pharmacy use, and prohibit pharmacy benefit manager

Read More »

News Alert

Some Provider Groups Slam NACHC and PhRMA’s 340B Plan, Others Say They’re Studying it

NACHC P&I
Lt. Cmdr. Emeka Egwim (left), Director of HRSA's Office of Pharmacy Affairs, spoke this morning on 340B Day at NACHC's annual Policy & Issues Forum in Washington, D.C.

A large HIV/AIDS health care group, a Democratic 340B provider ally in Congress, and three national hospital groups lambasted community health centers and drug makers’ historic announcement yesterday that they are working together to remake the 340B program.

Read More »

U.S. House Subcommittee Expected to Raise 340B During March 28 Hearing

House E&C
340B is expected to be addressed during a U.S. House Energy & Commerce health subcommittee hearing later this month.

The Republican-led U.S. House Energy & Commerce health subcommittee late yesterday announced a March 28 hearing on “how transparency and competition can lower health care costs for Americans.”

Although the hearing announcement is silent about the 340B

Read More »

Breaking News

Major Drug Industry and Health Center Groups Unite to Reform 340B for Patients and “True” Safety-Net Providers

ASAP 340B
PhRMA, NACHC, and and the National Hispanic Medical Association created a new group, ASAP 340B, and issued a 10-point plan to ensure that the 340B program “benefits patients and true safety-net providers, including rural hospitals.”

Pharmaceutical Research and Manufacturers of America, the National Association of Community Health Centers, and the National Hispanic Medical Association this morning jointly issued a 10-point plan and created a nonprofit group to ensure that the 340B program “benefits

Read More »

U.S. House Oversight Committee Launches PBM Investigation

House Committee on Oversight and Accountability
A U.S. House committee is investigating “anticompetitive tactics” by Express Scripts, CVS Caremark, and OptumRx.

The U.S. House Committee on Oversight and Accountability last week launched an investigation into how “anticompetitive tactics” by the three largest pharmacy benefit managers—Express Scripts, CVS Caremark, and OptumRx—are driving up healthcare costs and hurting patient care within

Read More »

NACHC Hill Day Document Calls for 340B Reform and Offers Guiding Principles, Key Hill Staffer Joins Organization

NACHC
“Health centers and their patients cannot afford more [contract pharmacy] restrictions or PBM discriminatory contracting," NACHC says in document urging Congress "to amend the 340B statute to protect access for the true safety-net providers.”

The National Association of Community Health Centers says in a new advocacy document “it’s time to reform the 340B program to recognize the complexities of today’s healthcare system and ensure that true safety-net providers continue to have access

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer